Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bayer seeks European approval for Eylea to treat myopic CNV
The MAA is based on positive data from the Phase III MYRROR trial, which randomized 122 patients to receive either aflibercept solution 2mg or sham. The multi-center, double-masked,
The MAA is based on positive data from the Phase III MYRROR trial, which randomized 122 patients to receive either aflibercept solution 2mg or sham. The multi-center, double-masked,
Under the deal, InMed’s Intelligent Cannabinoid Drug Design Platform (IDP) will be used to identify cannabinoid- and non-cannabinoid-based phytochemicals for ocular therapies focused on reducing various pro-inflammatory cytokines
The drug is approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA) in patients who achieve at least a partial response to prior
The open label single arm Phase II trial of PB272 monotherapy will involve a total of 70 patients with HER2-positive early stage breast cancer who have previously received
Temovate is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The launch strengthens the company’s growing portfolio of valuable topical products and shows
As per the information, the OTC liquid drugs manufactured at the company’s Fort Washington facility, including Infants’ and Children’s Tylenol and Infants’ and Children’s Motrin, were adulterated. They
Laboratory analysis conducted by the FDA has confirmed that UltraZx contains sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed for safety reasons from the market
Both the organizations will jointly work on research projects to identify new drug candidates. The two parties said they have identified three initial projects with a focus on
TELESTAR will evaluate the safety and tolerability of telotristat etiprate and its effect on symptoms associated with carcinoid syndrome, while top-line data is expected to be reported in
Scleroderma causes fibrosis of skin, joints and internal organs and predominately affects women in mid-life. Resunab is a new, oral specialized pro-resolving mediator drug and it binds to